SEC Form 4 · accession 0000899243-16-015531
Baxalta Inc · BXLT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jacopo Leonardi
Officer — EVP and President, Immunology
Period of report
Mar 7, 2016
Accepted (ET)
Mar 8, 2016 · 4:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001620546
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.01 per shareF1 | Mar 7, 2016 | F | 87 | $39.74 | D | 55,041 | D | |
| Common Stock, par value $0.01 per share | holding | — | — | — | 1,094 | I | By 401(k) Plan |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of partial vesting of restricted stock granted on March 5, 2013.